For research use only. Not for therapeutic Use.
BMS-986205 (Cat.No:I004741) is an anticancer drug candidate. Bristol-Myers Squibb is developing an orally administered BMS 986205 for the treatment of cancer.
| Catalog Number | I004741 |
| CAS Number | 1923833-60-6 |
| Synonyms | BMS-986205; BMS 986205; BMS986205.;(R)-N-(4-chlorophenyl)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide |
| Molecular Formula | C₂₄H₂₄ClFN₂O |
| Purity | ≥95% |
| Target | Indoleamine 2,3-Dioxygenase (IDO) |
| Solubility | Soluble in DMSO |
| Storage | 0 - 4 °C for short term or -20 °C for long term |
| IUPAC Name | (2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide |
| InChI | InChI=1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16?,17?/m1/s1 |
| InChIKey | KRTIYQIPSAGSBP-KLAILNCOSA-N |
| SMILES | InChI=1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16?,17?/m1/s1 |
